FDA Antidepressant Data Was Fully Disclosed, Agency Tells Congress

Although there was internal disagreement on the implications of pediatric antidepressant data, all information was reviewed publicly, the agency maintains in a letter to the House Energy & Commerce/Oversight Subcommittee.